Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes

NCT03406585 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type1 Diabetes Mellitus

Interventions

DRUG: ProTrans: Allogeneic transplantation with WJMSCs
DRUG: Placebos

Sponsor

NextCell Pharma Ab